PHAXIAM Therapeutics S.A.. American Depositary Shares
PHXM
PHXM was delisted on the 8th of March, 2024.
9 hedge funds and large institutions have $784K invested in PHAXIAM Therapeutics S.A.. American Depositary Shares in 2022 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 0 increasing their positions, 3 reducing their positions, and 1 closing their positions.
300% more first-time investments, than exits
New positions opened: 4 | Existing positions closed: 1
50% more funds holding
Funds holding: 6 → 9 (+3)
53% less capital invested
Capital invested by funds: $1.65M → $784K (-$867K)
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 3
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Mariner
Overland Park,
Kansas
|
+$58.9K |
| 2 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$10.9K |
| 3 |
ADL
Asset Dedication LLC
San Francisco,
California
|
+$3.96K |
| 4 |
IC
Ikarian Capital
Dallas,
Texas
|
+$2.99K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
-$51.6K |
| 2 |
VPIM
Vanguard Personalized Indexing Management
Oakland,
California
|
-$35.1K |
| 3 |
CS
Credit Suisse
Zurich,
Switzerland
|
-$5K |
| 4 |
UBS Group
Zurich,
Switzerland
|
-$4.35K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
BI
1
BVF Inc
San Francisco,
California
| $690K | – | – | – |
|
|
VPIM
2
Vanguard Personalized Indexing Management
Oakland,
California
| $33K | -$35.1K | -3,543 | -37% |
|
|
3
Mariner
Overland Park,
Kansas
| $33K | +$58.9K | +5,947 | New |
|
|
4
Citadel Advisors
Miami,
Florida
| $10K | -$51.6K | -5,211 | -74% |
|
5
Group One Trading
Chicago,
Illinois
| $6K | – | – | – |
|
|
6
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| $6K | +$10.9K | +1,101 | New |
|
|
7
UBS Group
Zurich,
Switzerland
| $2K | -$4.35K | -439 | -50% |
|
|
IC
8
Ikarian Capital
Dallas,
Texas
| $2K | +$2.99K | +302 | New |
|
|
ADL
9
Asset Dedication LLC
San Francisco,
California
| $2K | +$3.96K | +400 | New |
|
|
CS
10
Credit Suisse
Zurich,
Switzerland
| – | -$5K | -423 | Closed |
|
PHXM Hedge Fund Activity: Q3 2022 in Review
9 of the 5,806 institutional investors tracked by Wall St. Rank reported a position in PHAXIAM Therapeutics S.A.. American Depositary Shares (PHXM) for Q3 2022, worth a combined $784K — down 53% from $1.65M a quarter earlier.
Buyers outnumbered sellers: 4 funds opened new PHXM positions and 1 closed out — a net gain of 3 holders — while 0 added to existing stakes and 3 trimmed.
The largest buyer was Mariner, opening a new position worth an estimated $58.9K. The largest seller was Citadel Advisors, cutting an estimated $51.6K.
- 9 institutional investors held PHAXIAM Therapeutics S.A.. American Depositary Shares (PHXM) as of Q3 2022, up from 6 in Q2 2022.
- Funds reported $784K of PHAXIAM Therapeutics S.A.. American Depositary Shares stock for Q3 2022, down 53% quarter-over-quarter.
- 4 funds opened new PHAXIAM Therapeutics S.A.. American Depositary Shares positions in Q3 2022 and 1 closed out, a net change of +3 holders.
- The largest PHAXIAM Therapeutics S.A.. American Depositary Shares buyer in Q3 2022 was Mariner, an estimated $58.9K added.
- The largest PHAXIAM Therapeutics S.A.. American Depositary Shares seller in Q3 2022 was Citadel Advisors, an estimated $51.6K sold.
Based on aggregated 13F filings for Q3 2022.